AMC·AMC Entertainment Holdings, Inc.

AMC closes its 15-session tracking window with a complete canonical outcome of +0.83% from the $2.40 entry. The fresh after-market capture is $2.43, or +1.25% versus the reference, with 0.38x volume and a 2.62 > 2.44 > 2.17 EMA stack. The original Raw Try thesis correctly identified a dated earnings explanation and an observable price response, but neither durable follow-through nor primary confirmation was established. The episode is closed as a conditional thesis that is no longer followed.

AMC's tracked return is now +1.25%, a 0.21-point improvement from the previous public note, while the latest capture fell 6.07% on 0.33x participation and sits 0.30% below VWAP. The rising EMA stack and long-run company outperformance keep the catalyst case open, but a sector headwind and weak demand make this a pressure test rather than confirmation.

AMC's tracked return fell 2.60 percentage points as the latest capture dropped 6.68% on 0.16x participation and sat 1.75% below VWAP. The rising EMA structure and long-run sector outperformance keep the catalyst case open, but weak demand and the loss of VWAP make this a pressure test rather than confirmation.

AMC tracked return fell 4.28 percentage points from the last public update to +3.64%, turning the move into a sharper pressure test. The catalyst thesis remains conditional: the sealed packet lacks a current VWAP or market capture and still has no primary confirmation, so the pullback does not establish either continuation or failure.

AMC's tracked return rose 3.75 percentage points to +7.92% as the latest capture edged 0.78% higher on 0.36x participation. Rising EMAs, accumulation and a 37.39-point asset advantage versus the sector keep the catalyst case open, but weak demand, a sector headwind and unavailable VWAP evidence leave follow-through unconfirmed.

AMC's tracked return fell 2.91 percentage points to +4.17% as the latest capture dropped 2.72% on 0.14x participation. The rising EMA structure, accumulation and a 33.06-point sector advantage keep the catalyst case open, but price sits 0.39% below VWAP and weak demand leaves continuation under pressure.

AMC's latest capture fell 3.75% on 0.40x participation, while the rising EMA structure and longer-term relative strength keep the catalyst thesis open. Accumulation remains positive, but weak demand and unavailable VWAP evidence leave continuation under pressure.

AMC's tracked return fell 4.17 percentage points to +7.08%, while the current capture dropped 3.75% on 0.41x participation. The rising EMA structure and accumulation keep the catalyst thesis open, but the sharp session decline, no current VWAP capture and weak participation make this a pressure test rather than confirmed continuation.

AMC's tracked return is unchanged at +11.25%, while the latest capture eased 0.37% on 0.55x participation. Rising EMAs and a 38.50-point sector edge keep the catalyst thesis open, but weak demand and unavailable VWAP evidence make continuation a pressure test rather than an established trend.

AMC's tracked return improved 1.17 points to +11.25%, even as the latest capture eased 0.37% on 0.55x participation. Rising EMAs and a 38.50-point edge over the sector keep the catalyst thesis open, but weak demand and unavailable VWAP evidence make continuation a pressure test rather than an established trend.

AMC's tracked return improved 1.17 percentage points to +11.25%, while the latest capture eased 0.37% on 0.55x participation. Rising EMAs and accumulation keep the catalyst thesis open, but weak demand and a still-unconfirmed intraday support signal make continuation a pressure test rather than an established trend.

AMC's tracked return held at +11.67% even as the latest capture fell 1.68% to $2.64 and slipped 0.94% below VWAP on 0.16x participation. Rising EMAs and accumulation keep the catalyst thesis open, but weak demand and the loss of intraday support turn this into a pressure test; primary confirmation is still missing before continuation can be treated as established.

AMC kept its +11.67% tracked return even as the latest capture fell 5.96% to $2.68 on 0.89x participation. Rising EMAs and accumulation keep the catalyst thesis open, but the pullback and absent VWAP confirmation make continuation a pressure test.

AMC lost 5.96% in the latest session and slipped to a +11.67% tracked return, a 2.50-point deterioration from the previous update. The rising EMA structure and accumulation reading keep the broader catalyst thesis open, but weak participation and the absence of fresh confirmation make the current move a pressure test rather than confirmed continuation.

AMC gave back 4.58 points since the last update, leaving the tracked return at +14.17%; the $2.75 capture is down 3.51% and 1.08% below VWAP, while the rising EMA structure and accumulation reading have not yet been erased. That is a meaningful pressure test for the catalyst thesis: the trend survives structurally, but weak participation and lost VWAP make follow-through conditional until demand returns.

AMC remains at a +18.75% tracked return on day 11; the latest quote is $2.85, up 1.06% on 1.50x volume with an accumulation reading and a rising EMA structure. The broader move still supports the catalyst thesis, but RSI 76.33 and the unresolved primary confirmation keep follow-through conditional.

AMC tracked return eased 1.67 points from the last note but remains +20.42%; the latest capture is $2.85, up 1.06% on 1.50x volume with RSI 76.33. The rising EMA structure keeps the catalyst thesis supported, yet elevated momentum and pending primary confirmation leave follow-through conditional.

AMC added 3.75 percentage points since the last public note, taking the day-10 tracked return to +20.42%; the current quote is $2.89, up 2.57% on 1.28x relative volume. The stronger tape supports the catalyst thesis, but RSI 77.01 and unresolved primary confirmation keep follow-through conditional.

AMC slipped 0.83 points to +16.67% on day 10, with the current session down 1.06% on 0.69x relative volume. The rising EMA structure still supports the catalyst thesis, but price below VWAP and RSI 74.56 show that follow-through is digesting pending primary confirmation.

AMC holds +17.50% on day 10 as the current session adds 1.81% on 0.88x relative volume. The rising EMA structure keeps the catalyst thesis supported in price, but RSI at 77.14 and no new cumulative gain leave follow-through conditional pending primary confirmation.

AMC remains at +17.50% on day 9, with the current session up 1.81% on 0.88x relative volume and RSI at 77.14. The rising EMA structure continues to support the catalyst thesis in price, but the elevated momentum and unresolved primary confirmation keep follow-through conditional rather than established.

AMC is now at +17.50% on day 9 after adding 2.92 percentage points since the previous public note, with current price at $2.82, +1.81% session change and 0.88x relative volume. The rising EMA structure keeps the catalyst thesis supported in price, but elevated RSI and unresolved primary confirmation leave follow-through conditional rather than established.

AMC is now at +17.50% on day 9 after adding 2.92 percentage points since the previous public note, with current price at $2.82, +1.81% session change and 0.88x relative volume. The rising EMA structure keeps the catalyst thesis supported in price, but elevated RSI and unresolved primary confirmation leave follow-through conditional rather than established.

AMC now tracks at +14.58% on day 9 after a 0.72% pullback, with relative volume cooling to 0.65x while the rising EMA structure and elevated RSI remain visible. The catalyst thesis is holding in price, but the softer participation and unresolved primary confirmation keep follow-through conditional rather than established.

AMC now tracks at +14.58% on day 9 after a 0.72% pullback, with relative volume cooling to 0.65x while the rising EMA structure and elevated RSI remain visible. The catalyst thesis is holding in price, but the softer participation and unresolved primary confirmation keep follow-through conditional rather than established.

AMC is tracking at +13.75% on day 9 after a -1.80% session move, while relative volume is only 0.16x and RSI remains elevated at 74.29. The catalyst thesis still has price support, but the current pullback and light participation do not resolve the outstanding question of durable follow-through or primary confirmation.

AMC is tracking at +13.75% on day 9 after a -1.80% session move, while relative volume is only 0.16x and RSI remains elevated at 74.29. The catalyst thesis still has price support, but the current pullback and light participation do not resolve the outstanding question of durable follow-through or primary confirmation.

AMC now tracks at +15.42% on day 9 after a further 0.73% session gain, while relative volume has cooled to 0.7x and RSI is 75.58. Price action still supports the catalyst thesis, but durable participation and primary confirmation remain unresolved; the next check is whether the advance holds.

AMC now tracks at +15.42% on day 9 after a further 0.73% session gain, while relative volume has cooled to 0.7x and RSI is 75.58. Price action still supports the catalyst thesis, but durable participation and primary confirmation remain unresolved; the next check is whether the advance holds.

AMC added 2.92 percentage points from the last public update and now tracks at +15.42%, with the current session still positive. The catalyst thesis is gaining price support, but 0.7x relative volume leaves durable participation and confirmation of the underlying mechanism unresolved; the next check is whether the advance holds.

AMC added 2.92 percentage points from the last public update and now tracks at +15.42%, with the current session still positive. The catalyst thesis is gaining price support, but 0.7x relative volume leaves durable participation and confirmation of the underlying mechanism unresolved; the next check is whether the advance holds.

AMC advanced 1.67 percentage points since the last public update and now stands at +12.50% in tracking. The move continues to support the catalyst thesis, but confirmation of the underlying mechanism and durable participation remain open; the next check is whether the advance holds.

AMC advanced 1.67 percentage points since the last public update and now stands at +12.50% in tracking. The move continues to support the catalyst thesis, but confirmation of the underlying mechanism and durable participation remain open; the next check is whether the advance holds.

AMC has fallen 3.75 percentage points since the last public update and now stands at +10.83% in tracking. The earlier advance still supports the published catalyst thesis, but the pullback keeps primary confirmation and continued participation as the next checks.

AMC has fallen 3.75 percentage points since the last public update and now stands at +10.83% in tracking. The earlier advance still supports the published catalyst thesis, but the pullback keeps primary confirmation and continued participation as the next checks.

AMC remains at +14.58% in tracking, with no additional return change since the last public update. The advance still supports the published catalyst thesis, while continued participation and primary confirmation remain the next checks.

AMC remains at +14.58% in tracking, with no additional return change since the last public update. The advance still supports the published catalyst thesis, while continued participation and primary confirmation remain the next checks.

AMC is now at +14.58% in tracking, a +1.04 percentage-point change versus the last public update. The next check is whether this move holds with continued participation while the published thesis remains conditional.

AMC is now at +14.58% in tracking, a +1.04 percentage-point change versus the last public update. The next check is whether this move holds with continued participation while the published thesis remains conditional.

AMC has advanced 13.54 percentage points from its initial public reference since the last panel note. The move supports the published earnings-catalyst thesis, but the prepared evidence still lacks primary issuer confirmation; the next check is whether the advance sustains with participation.

AMC has advanced 13.54 percentage points from its initial public reference since the last panel note. The move supports the published earnings-catalyst thesis, but the prepared evidence still lacks primary issuer confirmation; the next check is whether the advance sustains with participation.

AMC is unchanged at a prepared return of +8.54%, holding above VWAP with 1.32x time-adjusted relative volume. The tape still supports the thesis, but the earnings mechanism remains without primary issuer confirmation and needs sustained participation.

AMC is unchanged at a prepared return of +8.54%, holding above VWAP with 1.32x time-adjusted relative volume. The tape still supports the thesis, but the earnings mechanism remains without primary issuer confirmation and needs sustained participation.

AMC remains at a prepared return of +8.54% after giving back 2.44 percentage points, with price above VWAP and 1.32x time-adjusted relative volume. The tape still supports the thesis, but the earnings mechanism lacks primary issuer confirmation and requires sustained participation.

AMC remains at a prepared return of +8.54% after giving back 2.44 percentage points, with price above VWAP and 1.32x time-adjusted relative volume. The tape still supports the thesis, but the earnings mechanism lacks primary issuer confirmation and requires sustained participation.

AMC remains at a prepared return of +10.98% after giving back 2.44 percentage points; price is above VWAP with 1.32x time-adjusted relative volume. The tape still supports the thesis, but the earnings mechanism lacks primary issuer confirmation and requires sustained participation.

AMC remains at a prepared return of +10.98% after giving back 2.44 percentage points; price is above VWAP with 1.32x time-adjusted relative volume. The tape still supports the thesis, but the earnings mechanism lacks primary issuer confirmation and requires sustained participation.

AMC’s prepared return has materially improved since the last panel baseline, supporting the tape side of the thesis. The earnings mechanism remains unconfirmed by primary issuer evidence, and sustained participation is the next check before treating the repair as durable.

AMC’s prepared return has materially improved since the last panel baseline, supporting the tape side of the thesis. The earnings mechanism remains unconfirmed by primary issuer evidence, and sustained participation is the next check before treating the repair as durable.

AMC improved from +0.61% to +2.03%, rising from $2.48 to $2.51 and moving above the initial $2.40 reference. The tape has repaired, but it still needs sustained participation and primary confirmation of the earlier earnings mechanism before the thesis is durable.

AMC improved from +0.61% to +2.03%, rising from $2.48 to $2.51 and moving above the initial $2.40 reference. The tape has repaired, but it still needs sustained participation and primary confirmation of the earlier earnings mechanism before the thesis is durable.

AMC moved from -7.72% to +2.03%, rising from $2.27 to $2.51 and crossing back above the initial $2.40 reference. The tape has materially repaired, but it still needs sustained participation and primary confirmation of the earlier earnings mechanism before the thesis can be treated as durable.

AMC moved from -7.72% to +2.03%, rising from $2.27 to $2.51 and crossing back above the initial $2.40 reference. The tape has materially repaired, but it still needs sustained participation and primary confirmation of the earlier earnings mechanism before the thesis can be treated as durable.

AMC is now +0.61%, an 8.33-point recovery from the prior -7.72% note, with the latest public price at $2.48 versus $2.27. The tape has repaired materially, but the recovery still needs to hold with real participation; no fresh issuer-specific event explains the move in the prepared evidence.

AMC is now +0.61%, an 8.33-point recovery from the prior -7.72% note, with the latest public price at $2.48 versus $2.27. The tape has repaired materially, but the recovery still needs to hold with real participation; no fresh issuer-specific event explains the move in the prepared evidence.

AMC is -7.72%, a modest 0.41-point recovery from the prior -8.13% note, with price at $2.27 versus $2.26. The tape has improved, but the recovery remains unresolved and no fresh issuer-specific event explains the move; the next check is whether repair can hold with real participation.

AMC is -7.72%, a modest 0.41-point recovery from the prior -8.13% note, with price at $2.27 versus $2.26. The tape has improved, but the recovery remains unresolved and no fresh issuer-specific event explains the move; the next check is whether repair can hold with real participation.

AMC is -7.72%, a modest 0.41-point recovery from the prior -8.13% note, with price at $2.27 versus $2.26. The tape has improved, but the recovery remains unresolved and no fresh issuer-specific event explains the move; the next check is whether repair can hold with real participation.

AMC is -7.72%, a modest 0.41-point recovery from the prior -8.13% note, with price at $2.27 versus $2.26. The tape has improved, but the recovery remains unresolved and no fresh issuer-specific event explains the move; the next check is whether repair can hold with real participation.

AMC improved from -13.01% to -8.13%, a 4.88-point recovery versus the previous public note, with range position rising to 0.292; however, the regular-session tape remains below VWAP at 2.27 versus 2.29 and participation has decelerated to 0.34 time RVOL. The existing Raw Try is therefore less severe but still unresolved, with no fresh issuer-specific event supporting a new explanation, selection or thesis reset.

AMC improved from -13.01% to -8.13%, a 4.88-point recovery versus the previous public note, with range position rising to 0.292; however, the regular-session tape remains below VWAP at 2.27 versus 2.29 and participation has decelerated to 0.34 time RVOL. The existing Raw Try is therefore less severe but still unresolved, with no fresh issuer-specific event supporting a new explanation, selection or thesis reset.

AMC deteriorated from -8.54% to -13.01%, a 4.47-point decline versus the previous public note. The tape remains below VWAP near the lower part of the range, while relative volume is only 0.47 and no issuer-specific event explains the move. The update Mesa therefore makes the reading more severe but leaves the cause and full thesis impact inconclusive.

AMC deteriorated from -8.54% to -13.01%, a 4.47-point decline versus the previous public note. The tape remains below VWAP near the lower part of the range, while relative volume is only 0.47 and no issuer-specific event explains the move. The update Mesa therefore makes the reading more severe but leaves the cause and full thesis impact inconclusive.

AMC improved 2.03 points from the prior update to -8.54% from its reference, but the rebound arrived without a fresh issuer catalyst or a clearer participation shift. The published thesis therefore remains unchanged for this check; sustained demand rather than a single recovery print would be needed to alter that reading.

AMC improved 2.03 points from the prior update to -8.54% from its reference, but the rebound arrived without a fresh issuer catalyst or a clearer participation shift. The published thesis therefore remains unchanged for this check; sustained demand rather than a single recovery print would be needed to alter that reading.

AMC remains at $2.20 and -10.57%, with the latest capture preserving the damaged structure described in the previous note rather than producing a repair. The panel finds no fresh issuer confirmation for the earnings-led thesis; a sustained VWAP reclaim with stronger participation is the missing signal, while another failure would leave the conditional case unsupported.

AMC is -10.57% from its reference. No new attributed catalyst or material structure change is available in this refresh, so the working thesis is unchanged; a panel update needs a clearer price, participation or information shift.

AMC has reversed from the prior public-review strength to $2.26, down 8.13% and sitting below VWAP at $2.37 in the bottom 4% of the regular-session range, despite 1.89x intraday RVOL. The earnings-led Raw Try is no longer supported by the tape: reclaiming VWAP would be the first repair signal, while continued acceptance below this area invalidates the conditional thesis and leaves supply in control.